- Home
- HUHU vs IOBT Comparison
HUHU vs IOBT Comparison
Compare HUHU & IOBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUHU
- IOBT
- Stock Information
- Founded
- HUHU 2015
- IOBT 2014
- Country
- HUHU China
- IOBT Denmark
- Employees
- HUHU N/A
- IOBT 79
- Industry
- HUHU
- IOBT Biotechnology: Pharmaceutical Preparations
- Sector
- HUHU
- IOBT Health Care
- Exchange
- HUHU NYSE
- IOBT Nasdaq
- Market Cap
- HUHU 106.3M
- IOBT 91.6M
- IPO Year
- HUHU 2024
- IOBT 2021
- Fundamental
- Price
- HUHU $6.78
- IOBT $1.40
- Analyst Decision
- HUHU
- IOBT Strong Buy
- Analyst Count
- HUHU 0
- IOBT 3
- Target Price
- HUHU N/A
- IOBT $9.33
- AVG Volume (30 Days)
- HUHU 25.8K
- IOBT 153.2K
- Earning Date
- HUHU 02-22-2025
- IOBT 08-12-2025
- Dividend Yield
- HUHU N/A
- IOBT N/A
- EPS Growth
- HUHU N/A
- IOBT N/A
- EPS
- HUHU N/A
- IOBT N/A
- Revenue
- HUHU $18,149,244.00
- IOBT N/A
- Revenue This Year
- HUHU N/A
- IOBT N/A
- Revenue Next Year
- HUHU N/A
- IOBT N/A
- P/E Ratio
- HUHU N/A
- IOBT N/A
- Revenue Growth
- HUHU 8.47
- IOBT N/A
- 52 Week Low
- HUHU $2.95
- IOBT $0.66
- 52 Week High
- HUHU $9.89
- IOBT $1.73
- Technical
- Relative Strength Index (RSI)
- HUHU N/A
- IOBT 51.29
- Support Level
- HUHU N/A
- IOBT $1.37
- Resistance Level
- HUHU N/A
- IOBT $1.52
- Average True Range (ATR)
- HUHU 0.00
- IOBT 0.09
- MACD
- HUHU 0.00
- IOBT -0.01
- Stochastic Oscillator
- HUHU 0.00
- IOBT 46.63
About HUHU HUHUTECH INTL GROUP INC
HUHUTECH International Group Inc specializes in providing factory facility management and monitoring systems, including high-purity gas, chemicals and liquid system and factory management and control systems for industrial clients, who are mainly semi-conductor manufacturers and electronics manufacturers in China. The products and services are widely used by semi-conductor manufacturers, LED and micro-electronics factories, as well as some pharmaceutical, food and beverage manufacturers.
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.